HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brigette B Y Ma Selected Research

Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)

12/2021Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.
1/2021Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma.
1/2021Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer.
7/2018Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial.
10/2017Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.
2/2014Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models.
11/2013Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing.
2/2013Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines.
11/2008Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.
4/2007Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma--a prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brigette B Y Ma Research Topics

Disease

40Nasopharyngeal Carcinoma
05/2022 - 11/2002
37Neoplasms (Cancer)
01/2022 - 10/2002
10Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2021 - 04/2007
7Neoplasm Metastasis (Metastasis)
01/2022 - 10/2006
7Colorectal Neoplasms (Colorectal Cancer)
12/2018 - 11/2007
6Hepatocellular Carcinoma (Hepatoma)
11/2013 - 01/2009
3Disease Progression
01/2021 - 01/2017
3Hypoxia (Hypoxemia)
11/2008 - 04/2007
2Necrosis
05/2022 - 12/2011
2Head and Neck Neoplasms (Head and Neck Cancer)
04/2022 - 11/2008
2Carcinogenesis
01/2021 - 08/2010
2Infections
07/2018 - 02/2009
2Liver Neoplasms (Liver Cancer)
01/2018 - 02/2011
2Glioblastoma (Glioblastoma Multiforme)
06/2012 - 06/2011
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Fatigue
12/2021
1Pruritus (Itching)
12/2021
1Epstein-Barr Virus Infections
01/2021
1Colonic Neoplasms (Colon Cancer)
12/2018
1Retinoblastoma (Glioblastoma, Retinal)
01/2018
1Sarcoma (Soft Tissue Sarcoma)
11/2013
1Breast Neoplasms (Breast Cancer)
11/2013
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2013
1Lung Neoplasms (Lung Cancer)
11/2013
1Vaccinia
03/2013
1Glioma (Gliomas)
06/2012

Drug/Important Bio-Agent (IBA)

20DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2002
9Biomarkers (Surrogate Marker)IBA
03/2020 - 11/2008
7Cisplatin (Platino)FDA LinkGeneric
08/2015 - 12/2002
4PlatinumIBA
12/2021 - 01/2005
3Oncogene Proteins (Oncogene Protein)IBA
07/2018 - 10/2003
3ErbB Receptors (EGF Receptor)IBA
01/2014 - 10/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 04/2007
3Cetuximab (Erbitux)FDA Link
06/2010 - 05/2005
2RNA (Ribonucleic Acid)IBA
01/2022 - 12/2021
2AntibodiesIBA
01/2021 - 01/2014
2Pharmaceutical PreparationsIBA
10/2015 - 12/2013
2EverolimusFDA Link
06/2013 - 08/2010
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2011 - 01/2009
2Messenger RNA (mRNA)IBA
11/2008 - 11/2007
2Proteins (Proteins, Gene)FDA Link
11/2008 - 10/2003
2Carboplatin (JM8)FDA LinkGeneric
05/2005 - 08/2004
1fangchinoline (limacine)IBA
01/2022
1spartalizumabIBA
12/2021
1Contrast MediaIBA
09/2021
1LigandsIBA
01/2021
1Transforming Growth Factor-beta Type II ReceptorIBA
01/2021
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1NucleotidesIBA
01/2020
1AmidesIBA
02/2019
1Protons (Proton)IBA
02/2019
1Capecitabine (Xeloda)FDA Link
12/2018
1Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2018
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2018
1NivolumabIBA
10/2018
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2018
1B7-H1 AntigenIBA
10/2018
1ribociclibIBA
01/2018
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2018
1AlpelisibIBA
01/2018
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2018
1Axitinib (AG 013736)IBA
01/2018
1Cyclin D1IBA
01/2018
1Investigational DrugsIBA
06/2017
1Phosphotransferases (Kinase)IBA
06/2017
1Codon (Codons)IBA
08/2015
1AdenineFDA LinkGeneric
08/2015
1ThymineIBA
08/2015
1CytosineIBA
08/2015
1Monoclonal AntibodiesIBA
06/2014
1dactolisibIBA
02/2014
1AmphiregulinIBA
12/2013
1Transforming Growth Factor alpha (TGF-alpha)IBA
12/2013
1XELOXIBA
12/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2013
12- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA
12/2013
1hydrogen sulfite (bisulfite)IBA
11/2013
1MK 2206IBA
06/2013
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
06/2013
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
03/2013
1Tumor Viral Antigens (Large T Antigen)IBA
03/2013
1AntigensIBA
03/2013
1Membrane Proteins (Integral Membrane Proteins)IBA
03/2013
1VaccinesIBA
03/2013
1AZD 6244IBA
02/2013
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2013
1Vitamin EFDA LinkGeneric
09/2012
1O(6)-Methylguanine-DNA MethyltransferaseIBA
06/2012
1Sorafenib (BAY 43-9006)FDA Link
06/2012

Therapy/Procedure

20Radiotherapy
04/2022 - 11/2002
14Drug Therapy (Chemotherapy)
12/2021 - 12/2002
10Therapeutics
01/2021 - 07/2008
5Adjuvant Chemotherapy
01/2021 - 01/2005
4Chemoradiotherapy
01/2018 - 06/2011
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2022 - 11/2004
2Immunotherapy
04/2022 - 06/2017
2Induction Chemotherapy
01/2020 - 01/2018
2Organ Transplantation
01/2019 - 01/2018
1Liver Transplantation
01/2018